Brian Lian insider trades: Viking Therapeutics (VKTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Brian reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | VKTX | ↓ Sell | 148,517 | $33.32 | $4.9M | Direct | Jul 29, 2026 (0d) |
| Jan 5, 2026 | VKTX | ↓ Sell | 233,409 | $32.96 | $7.7M | Direct | Jan 5, 2026 (0d) |
| Oct 28, 2025 | VKTX | ↓ Sell | 38,989 | $35.01 | $1.4M | Direct | Oct 28, 2025 (0d) |
| Jul 3, 2025 | VKTX | ↓ Sell | 26,889 | $27.80 | $748K | Direct | Jul 3, 2025 (0d) |
| Jan 6, 2025 | VKTX | ↓ Sell | 194,490 | $42.75 | $8.3M | Direct | Jan 6, 2025 (0d) |
| Sep 20, 2024 | VKTX | ↓ Sell | 216,130 | $70.83 | $15.3M | Direct | Sep 20, 2024 (0d) |
| Aug 21, 2024 | VKTX | ↓ Sell | 1,000 | $69.90 | $70K | Direct | Aug 22, 2024 (1d) |
| Aug 19, 2024 | VKTX | ↓ Sell | 112,870 | $65.80 | $7.4M | Direct | Aug 19, 2024 (0d) |
| Jul 30, 2024 | VKTX | ↓ Sell | 115,859 | $57.58 | $6.7M | Direct | Jul 31, 2024 (1d) |
| Feb 9, 2024 | VKTX | ↓ Sell | 45,000 | $29.90 | $1.3M | Direct | Feb 9, 2024 (0d) |
| Feb 8, 2024 | VKTX | ↓ Sell | 269,079 | $26.87 | $7.2M | Direct | Feb 8, 2024 (0d) |
| Jan 31, 2024 | VKTX | ↓ Sell | 85,000 | $24.71 | $2.1M | Direct | Jan 31, 2024 (0d) |
| Jan 30, 2024 | VKTX | ↓ Sell | 35,000 | $23.95 | $838K | Direct | Jan 30, 2024 (0d) |
| May 1, 2023 | VKTX | ↓ Sell | 45,000 | $22.45 | $1.0M | Direct | May 1, 2023 (0d) |
| Apr 19, 2023 | VKTX | ↓ Sell | 35,000 | $21.45 | $751K | Direct | Apr 21, 2023 (2d) |
| Apr 17, 2023 | VKTX | ↓ Sell | 155,000 | $20.45 | $3.2M | Direct | Apr 18, 2023 (1d) |
| Apr 13, 2023 | VKTX | ↓ Sell | 79,336 | $18.45 | $1.5M | Direct | Apr 13, 2023 (0d) |
| Apr 3, 2023 | VKTX | ↓ Sell | 243,352 | $17.31 | $4.2M | Direct | Apr 3, 2023 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VKTX insiders
Open-market trades in the last 12 months
About Brian Lian's insider trades
Brian Lian is President & CEO at Viking Therapeutics (VKTX). Since Apr 3, 2023, Brian has reported no open-market purchases and 18 sales worth $74.7M on SEC Form 4. In the last 12 months: 2 sales ($12.6M).
Their filings also include grants and awards (28 filings), shares withheld for taxes (15 filings), option exercises (9 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VKTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.